Loading...

Reminder: Do not include any PHI or PII in JIRA. If you require 508 accessibility assistance, then please send an email to onc-jira-questions@healthit.gov

Login Support: If you encounter a captcha prompt, login issues, or believe your account may be deactivated and require assistance, please send an email to onc-jira-questions@healthit.gov

HHS System Use Notification
This warning banner provides privacy and security notices consistent with applicable federal laws, directives, and other federal guidance for accessing this Government system, which includes all devices/storage media attached to this system. This system is provided for Government-authorized use only. Unauthorized or improper use of this system is prohibited and may result in disciplinary action and/or civil and criminal penalties. At any time, and for any lawful Government purpose, the government may monitor, record, and audit your system usage and/or intercept, search and seize any communication or data transiting or stored on this system. Therefore, you have no reasonable expectation of privacy. Any communication or data transiting or stored on this system may be disclosed or used for any lawful Government purpose.

Every Saturday the ONC Issue Tracking System, including Confluence, will be unavailable for weekly maintenance between 10pm EST and the following morning at 3am EST.

XML

Word

Printable

Details

Type: Question/Guidance
Resolution: Unresolved
Priority: Moderate
Labels:
None

Description

Please see attached comments from the American Society of Clinical Oncology.

Attachments

- - Sort By Name
  - Sort By Date
  - Ascending
  - Descending
  - Thumbnails
  - List
  - Download All

ASCO_USCDI+Comments_Submission_6-30-2023.pdf
140 kB
06/30/23 2:08 PM

Activity

People

Assignee:: Unassigned

Reporter:: Karen Hagerty

Votes:: 0 Vote for this issue

Watchers:: 1 Start watching this issue

Dates

Created:: 06/30/23 2:08 PM

Updated:: 06/30/23 2:08 PM